HIV-1 DNA predicts disease progression and post-treatment virological control JP Williams, J Hurst, W Stöhr, N Robinson, H Brown, M Fisher, S Kinloch, ... elife 3, e03821, 2014 | 325 | 2014 |
Short-course antiretroviral therapy in primary HIV infection SPARTAC Trial Investigators New England Journal of Medicine 368 (3), 207-217, 2013 | 241 | 2013 |
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa MA Price, CL Wallis, S Lakhi, E Karita, A Kamali, O Anzala, EJ Sanders, ... AIDS research and human retroviruses 27 (1), 5-12, 2011 | 154 | 2011 |
Evolution and diversity of HIV-1 in Africa–a review MA Papathanasopoulos, GM Hunt, CT Tiemessen Virus genes 26, 151-163, 2003 | 100 | 2003 |
Multiple Bacteriocin Production by Leuconostoc mesenteroidesTA33a and Other Leuconostoc/Weissella Strains MA Papathanasopoulos, F Krier, AM Revol-Junelles, G Lefebvre, ... Current Microbiology 35, 331-335, 1997 | 88 | 1997 |
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection E Hamlyn, FM Ewings, K Porter, DA Cooper, G Tambussi, M Schechter, ... Public Library of Science 7 (8), e43754, 2012 | 85 | 2012 |
Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa BJ Connell, K Michler, A Capovilla, WDF Venter, WS Stevens, ... Aids 22 (7), 896-899, 2008 | 79 | 2008 |
Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1 CT Tiemessen, S Shalekoff, S Meddows-Taylor, DB Schramm, ... The Journal of Immunology 182 (10), 5914-5918, 2009 | 78 | 2009 |
Characterization of leucocin B-Ta11a: A bacteriocin fromLeuconostoc carnosum Ta11a isolated from meat JV Felix, MA Papathanasopoulos, AA Smith, A von Holy, JW Hastings Current Microbiology 29, 207-212, 1994 | 77 | 1994 |
Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1 CL Wallis, MA Papathanasopoulos, S Lakhi, E Karita, A Kamali, ... Journal of virological methods 163 (2), 505-508, 2010 | 73 | 2010 |
Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression I Choge, T Cilliers, P Walker, N Taylor, M Phoswa, T Meyers, J Viljoen, ... AIDS Research & Human Retroviruses 22 (5), 458-465, 2006 | 66 | 2006 |
Sequence and structural relationships of leucocins A-, B- and C-TA33a from Leuconostoc mesenteroides TA33a MA Papathanasopoulos, GA Dykes, AM Revol-Junelles, A Delfour, ... Microbiology 144 (5), 1343-1348, 1998 | 66 | 1998 |
Use of alternate coreceptors on primary cells by two HIV-1 isolates T Cilliers, S Willey, WM Sullivan, T Patience, P Pugach, M Coetzer, ... Virology 339 (1), 136-144, 2005 | 64 | 2005 |
Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa MA Papathanasopoulos, T Cilliers, L Morris, JL Mokili, W Dowling, DL Birx, ... AIDS research and human retroviruses 18 (12), 879-886, 2002 | 60 | 2002 |
Moderate levels of pre-treatment HIV-1 antiretroviral drug resistance detected in the first South African National Survey K Steegen, S Carmona, M Bronze, MA Papathanasopoulos, G Van Zyl, ... PloS one 11 (12), e0166305, 2016 | 57 | 2016 |
HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa K Steegen, M Bronze, MA Papathanasopoulos, G van Zyl, D Goedhals, ... Journal of Antimicrobial Chemotherapy 72 (1), 210-219, 2016 | 55 | 2016 |
High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa L Skhosana, K Steegen, M Bronze, A Lukhwareni, E Letsoalo, ... PloS one 10 (2), e0118145, 2015 | 51 | 2015 |
Structured observations reveal slow HIV-1 CTL escape HE Roberts, J Hurst, N Robinson, H Brown, P Flanagan, L Vass, S Fidler, ... PLoS genetics 11 (2), e1004914, 2015 | 47 | 2015 |
Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization N Cerutti, M Killick, V Jugnarain, M Papathanasopoulos, A Capovilla Journal of Biological Chemistry 289 (15), 10455-10465, 2014 | 46 | 2014 |
Sensitivity of HIV type 1 subtype C isolates to the entry inhibitor T-20 T Cilliers, T Patience, C Pillay, M Papathanasopoulos, L Morris AIDS research and human retroviruses 20 (5), 477-482, 2004 | 44 | 2004 |